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Targeted disruption of MCPIP1/Zc3h12a results
in fatal inflammatory disease
Ruidong Miao1,2,7, Shengping Huang1,7, Zhou Zhou3,7, Tim Quinn1, Benjamin Van Treeck1, Tehreem Nayyar1,
Daniel Dim4, Zhisheng Jiang5, Christopher J Papasian1, Y Eugene Chen3, Gang Liu6 and Mingui Fu1
Previous studies using MCP-induced protein 1 (MCPIP1)/Zc3h12a-deficient mice suggest that MCPIP1 is an important
regulator of inflammation and immune homeostasis. However, the characterization of the immunological phenotype of MCPIP1-
deficient mice has not been detailed. In this study, we performed evaluation through histological, flow cytometric, enzyme-
linked immunosorbent assay and real-time PCR analysis and found that targeted disruption of MCPIP1 gene leads to fatal,
highly aggressive and widespread immune-related lesions. In addition to previously observed growth retardation, splenomegaly,
lymphoadenopathy, severe anemia and premature death, MCPIP1-deficient mice showed disorganization of lymphoid organs,
including spleen, lymph nodes and thymus, and massive infiltration of lymphocytes, macrophages and neutrophils into many
other non-lymphoid organs, primarily in lungs and liver. Flow cytometric analysis found significant increase in activated and
differentiated T cells in peripheral blood and spleen of MCPIP1-deficient mice. Moreover, heightened production of
inflammatory cytokines from activated macrophages and T cells were observed in MCPIP1-deficient mice. Interestingly,
treatment of MCPIP1-deficient mice with antibiotics resulted in significant improvement of life span and a decrease in
inflammatory syndrome. Taken together, these results suggest a prominent role for MCPIP1 in the control of inflammation and
immune homeostasis.
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As the immune system is continuously bombarded with foreign
antigens, complex regulatory mechanisms interact to maintain
immune homeostasis. Specifically, the inflammatory and immune
responses must be sufficient to eliminate invading antigens, but the
inflammatory response should not be sustained after the threat has
been eliminated and, ideally, the invader should be eliminated
without substantial collateral damage to the surrounding tissues.1,2
The molecular mechanisms contributing to the maintenance of
immune homeostasis are not fully understood. We and others
recently identified a novel member of CCCH-zinc finger protein
family, designated as MCP-induced protein 1 (MCPIP1) (also known
as Zc3h12a), which is 65.8 kDa protein encoded by the immediate-
early response gene, Zc3h12a.3–7 This gene has been mapped to
chromosome 4 in mouse, and the equivalent gene in human,
ZC3H12A, has been mapped to chromosome 1p34.3. In adult
mouse, MCPIP1 mRNA is highly expressed in the lung, intestine,
colon, lymph node, spleen and thymus. MCPIP1 mRNA is expressed
at lower levels in the stomach, bladder, adipose tissue and the aorta,
and is essentially absent in the brain, kidney, liver, heart and skeletal
muscle.8 Several members of the MCPIP1 family, including MCPIP1/
Zc3h12a, Zc3h12b, Zc3h12c and Zc3h12d, were previously reported
to contribute to negative regulation of lipopolysaccharide-induced
macrophage activation.4 These initial findings were further confirmed
by observations in MCPIP1-deficient mice.8,9 MCPIP1-deficient mice
develop normally in utero. However, with age, they begin to suffer
from spontaneous inflammatory diseases characterized by multiorgan
inflammation, splenomegaly, heightened inflammatory cytokine
production and premature death.8,9 MCPIP1-deficient cells are
hyper-responsive to Toll-like receptor signaling, and MCPIP1-
deficient mice are hypersensitive to septic shock.10 Furthermore, we
and others have recently shown that MCPIP1 is a multifunctional
protein that actively participates in several distinct signaling pathways.
For example, MCPIP1 downregulates lipopolysaccharide-induced
inflammatory responses by acting as an RNase;9,11 MCPIP1 inhibits
C-Jun N-terminal kinase (JNK) and nuclear factor-kB signaling by
interfering with the ubiquitination of upstream signaling molecules,
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such as TNF receptor associate factors.8 These results collectively
suggest that MCPIP1 is a novel antiinflammatory protein that
negatively regulates both innate and adaptive immunity, and that
its selective expression in lymphoid and inflamed tissues suppresses
hyper-responsiveness, thereby contributing to the maintenance of
immune homeostasis.
The goal of the current study was to further characterize the
phenotypes of MCPIP1-deficient mice through histological, flow
cytometric, enzyme-linked immunosorbent assay and real-time PCR
analysis. We found that targeted disruption of MCPIP1 gene resulted
in fatal disseminated inflammation, which was characterized by
disrupted architecture of primary and secondary lymphoid organs,
leukocytic infiltration of lungs and liver, activation of T cells and
B cells and enhanced levels of both macrophage and T cell-derived
cytokines. These results demonstrated a prominent role for MCPIP1
in control of inflammation and immune homeostasis.
RESULTS
Primary and secondary lymphatic tissues of MCPIP1-deficient
mice exhibit architectural disorganization
Despite the striking phenotypic changes reported for MCPIP1/
mice in our previous study,8 the detailed pathogenesis of these
alterations was not fully analyzed. Consquently, in the current
study, we further characterized the changes occurring in the major
organs and tissues, including the thymus, spleen, lymph nodes, lungs,
liver, heart, aorta, kidney, skin and intestine and so on, from
MCPIP1-deficient mice by histological, flow cytometric and real-
time PCR analysis. The most strinking morphological changes were
observed in the spleen, lymph nodes and thymus of MCPIP1-
deficient mice. As shown in Figure 1a, the architecture of the spleen,
lymph nodes and thymus from both male and female MCPIP1-
deficient mice at 8 weeks of age appeared disorganized. In the spleen,
the white pulp appeared underdeveloped, whereas the red pulp had
marked expansion, probably a result of extramedullary hematopoiesis.
Such pathology disrupted normal splenic architecture. In lymph
nodes of MCPIP1-deficient mice, normal follicular architecture of the
cortex was missing, which was probably caused by underdevelopment.
The paracortical areas were also disorganized. In the thymus, the
cortex was essentially absent and the medulla was significantly
expanded. To investigate the development of this architectural
disruption with age, we futher observed the phenotype of MCPIP1-
deficient mice at the ages of 2 days, 3 weeks and 6 weeks. As shown in
Figures 1b–d, the gross size and histological morphology of spleens
from MCPIP1/ mice at the age of 2 days were essentially normal
compared with those from wild-type littermates. By 3 weeks of age,
spleens from MCPIP1/ mice were obviously larger than those from
MCPIP1þ /þ littermates, and these differences became even more
pronounced by 6 weeks of age. These results suggest that the
architectural abnormalities observed in primary and secondary
lymphatic tissues of MCPIP1-deficient mice progressed with age.
MCPIP1-deficient mice exhibit multiorgan inflammation
The gross architecture of the non-lymphoid organs from MCPIP1-
deficient mice was essentially normal compared with that from wild-
type littermates (at the age of 8 weeks). Microscopically, however,
multifocal and mixed inflammatory cell infiltration was observed in
many of these organs, with the most severe changes occurring in the
lungs and liver from MCPIP1-deficient mice (Figure 2 and
Supplementary Figure S1). At 3 weeks of age, leukocyte infiltration
into the interstitial spaces of the lungs was observed in MCPIP1/
mice, but not in MCPIP1þ /þ mice (Figure 2a). By 8 weeks of age,
massive infiltration of leukocytes into the interstitial spaces of the lungs,
marked by thickening of the alveolar septa and pulmonary edema were
observed in MCPIP1/ mice, but not in MCPIP1þ /þ mice. Large
amounts of mucus also filled the terminal bronchioles and alveolar
spaces of MCPIP1/ mice by 8 weeks. In the liver, inflammatory cell
infiltration in the portal triad area, with infiltrates most concentrated
near the bile ducts, was observed in MCPIP1/ mice, but not in
MCPIP1þ /þ mice (Figure 2b). Mild-to-moderate inflammatory cell
infiltration was also observed in the intestines, and kidneys from
MCPIP1/ mice. It was also noted that transmural thickening of the
intestine also appeared in MCPIP1/ mice. In the kidneys of
MCPIP1/ mice, the glomeruli were larger with a skewed matrix
to nuclei ratio (Supplementary Figure S1). There was no microscopic
evidence of bacterial invasion into these tissues. No significant
inflammation was observed in other tissues of MCPIP1/ mice,
such as heart, aorta and skin, despite there was some minor
inflammatory cell infiltration into adipose tissue surrounding the
aorta (Supplementary Figure S1). Immunohistochemical staining
demonstrated that most of the inflammatory cells in the lungs were
B lymphocytes and macrophages, whereas in the liver, predominately
neutrophils and macrophages (Figure 2c).
MCPIP1-deficient mice exhibit increased immunoglobulin
accumulation in multiple tissues
Previous report showed that MCPIP1/Zc3h12a null mice developed
hyperimmunoglobulinemia of all immunoglobulin (Ig) isotypes.9
Antinuclear antibodies and anti-double-stranded-DNA antibodies
were also detected in MCPIP1/Zc3h12a null mice.9 In the current
study, immunofluorescent staining revealed increased accumulation
of IgM and IgG in multiple organs from MCPIP1/ mice, including
spleen, skin, lungs and aorta, but not in those from MCPIP1þ /þ
mice (Figure 3). Interestingly, the accumulation of immune complex
was not obvious in the kindey from MCPIP1/ mice (Figure 3).
Nevertheless, these results demonstrated that MCPIP1-deficient mice
spontanously developed an autoimmune response.
Immune cell abnormalities in MCPIP1-deficient spleens
To further characterize the cellular components of the systemic
inflammation in MCPIP1-deficient mice, we performed flow cyto-
metry analysis of cell populations in the spleens of MCPIP1/ and
MCPIP1þ /þ mice. First, we analyzed nucleated spleen cells to
determine the percentage of B cells, T cells, neutrophils and
monocytes, and found that the percentage of B cells in the spleen
was dramatically decreased, the percentage of neutrophils was
markedly increased, and the percentage of T cells was moderately
decreased in MCPIP1/ mice; monocytes remained essentially
unchanged (Figure 4a). Interestingly, although B cells represented a
relatively small percentage of nucleated cells in the spleens of
MCPIP1/ mice (B7%), a surprisingly high proportion of these
cells had differentiated into plasma cells (B25%) (Figure 4a). To
further explore lymphocyte activation within the spleen, we studied
various T-cell populations. Specifically, we compared the levels of
activation of CD4þ and CD8þ cells from the spleens of MCPIP1/
and MCPIP1þ /þ mice using the specific markers for activated T cells
(CD62L), Th1 (interferon, IFN-g), and Th2 (interleukin-4, IL-4). As
shown in Figures 4b and c, CD62Llow was significantly upregulated in
both CD4þ and CD8þ cells from MCPIP1/ mice compared with
those from MCPIP1þ /þ mice, suggesting that T cells were auto-
maticlly activated in MCPIP1/ mice. Moreover, INFg was also
significantly upregulated in both CD4þ and CD8þ cells from
MCPIP1/ mice and IL-4 was significantly elevated in CD4þ cells,
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but not in CD8þ cells of MCPIP1/ mice (Figure 4c). These
findings support that lymphocyte activation and differentiation were
profoundly enhanced in the spleens of MCPIP1/ compared with
that in MCPIP1þ /þ mice. In addition, the percentage of both CD4þ
and CD8þ cells expressing IL-17 was significantly increased in
MCPIP1/ compared with MCPIP1þ /þ mice (Figure 4c). In view
of the profound proinflammatory effects of IL-17, it is probable that
enhanced expression of IL-17 in MCPIP1/ mice contributed to
acute inflammatory changes observed within the spleens from these
mice. Somewhat surprisingly, Foxp3-expressing cells were also more
prominent in the spleens from MCPIP1/ mice, particularly among
CD4þ cells (Figures 4b and c). Consequently, the profound inflam-
matory response in the spleens of MCPIP1/ mice could not be
attributed to deficient numbers of Treg cells.
Figure 1 Disorganization of lympoid organs from MCPIP1/ mice. (a) Hematoxylin and eosin (H&E) staining of formalin-fixed spleen, lymph node and
thymus sections from both male and female MCPIP1/ mice and wild-type littermates (MCPIP1þ /þ ) at the age of 8–10 weeks. Magnitude is 100
except indicated. Bar¼100mm. (b) Gross morphology of the spleen from MCPIP1þ /þ and MCPIP1/ mice at the indicated age. (c) H&E staining of the
spleen from MCPIP1þ /þ and MCPIP1/ mice at the indicated age. Bar¼100mm. (d) The spleen weight from MCPIP1þ /þ and MCPIP1/ mice at the
indicated age. N¼3. *Po0.05 vs wild-type group.
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Figure 2 Development of multiorgan inflammation in MCPIP1/ mice. (a) H&E staining of formalin-fixed lung sections from MCPIP1/ mice and wild-
type littermates at the indicated age. (b) H&E staining of formalin-fixed liver sections from MCPIP1/ mice and wild-type littermates at the indicated age.
(c) Immunohistochemical staining of formalin-fixed liver and lung sections from MCPIP1 null mice and wild-type littermates at the age of 8 weeks with
B-cell marker (anti-B220) and macrophage marker (anti-F4/80).
Figure 3 Ig accumulation in MCPIP1/ mice. Immunofluoresence staining of formalin-fixed kidney, aorta, lung, skin and spleen sections from MCPIP1/
mice and wild-type littermates at the age of 8 weeks with anti-IgM and anti-IgG. The layers of aorta have been marked as ‘A’ (adventitial), ‘M’ (media layer)
and ‘L’ (lumen).
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MCPIP1-deficient mice exhibit increased protein and mRNA levels
for markers of innate and adaptive immunity
To further delineate the molecular mechanisms underlying the fatal
inflammation in MCPIP1/ mice, we examined protein level of 23
proinflammatory cytokines, chemokines and other markers of
inflammation in serum of 2-month-old mice (not all data are
shown). As shown in Figure 5a, the proinflammatory cytokines from
both innate cells (such as IL-1, IL-6, monocyte chemotactic protein-1
and TNFa) and adaptive immune cells (such as IL-2, IL-3, IL-4, IL-5,
IL-12p40, IL-13, IL-17 and IFNg) were all increased in the serum
from MCPIP1/ mice compared with that from MCPIP1þ /þ mice.
Moreover, the mRNA levels for MD2, Toll-like receptor4, CD14 and
IL-6 were significantly increased in the spleens from MCPIP1/
compared with MCPIP1þ /þ mice (Figure 5b). No significant
differences were observed in mRNA levels for TNFa, IL-1b, monocyte
chemotactic protein-1, and inducible nitric oxide synthase in the
spleens from both genotypes, suggesting that other sources may
contribute the expression levels of these inflammatory cytokines.
Figure 4 Immune-cell abnormalities in MCPIP1-deficient spleens. Single-cell suspensions of spleens from 6-week-old wild-type and MCPIP1/ mice were
counted and stained for flow cytometric analysis. (a) The percentage of total T cells, B cells, neutrophils and monocytes in total nucleared cells, and the
percentage of B cells that had differentiated to plasma cells were reported as mean±s.d., n¼3. *Po0.01 vs wild-type mice. (b) Flow cytometry plots for
CD62L, IFNg, and Foxp3 in CD4þ and CD8þ cells. (c) The percentage of subtypes of T cells in both CD4þ and CD8þ T-cell populations were reported as
mean±s.d., n¼3. *Po0.01 vs wild-type mice.
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Consistent with the results above, the mRNA levels for many T-cell
cytokines, including IFN-g, IL-4, IL-5, IL-13 and IL-17 were markedly
elevated in MCPIP1/ compared with MCPIP1þ /þ mice
(Figure 5c). However, the expression levels of T-bet, GATA3 and
RORg were not changed, suggesting that MCPIP1 may directly
regulate the mRNA degradation of IFN-g, IL-4 and IL-17, but not
their transcription. Among the B-cell markers, the expression marker
of B-cells progenitors, c-Kit, was upregulated in MCPIP1/ spleens;
however, the expression of transcription factors for B-cells develop-
ment, early B-cell factor 1 and Pax5, was downregulated in MCPIP1-
deficient mice (Figure 5d). Interestingly, the expression of both
Zc3h12b and Zc3h12c, but not Zc3h12d were compensatory increased
in the spleen from MCPIP1/ mice (Figure 5e). Taken together,
these results further demonstrated that the fatal inflammatory
syndrome in MCPIP1/ mice was associated with an abnormal
response of both innate and adaptive immune cells.
Antibiotic treatment improves the life span and inflammatory
syndrome of MCPIP1-deficient mice
The indigenous microbiota of mucosal surfaces, particularly the
intestinal microflora, accounts for a substantial proportion of the
stimulus to our innate and adaptive immune systems.12,13 To test
whether the indigenous microbiota contributed to the development of
inflammatory phenotypes of MCPIP1-deficient mice, we treated
MCPIP1-deficient and wild-type mice from birth to 10 weeks with
a combination of oral antibiotics that would greatly deplete the
microflora of the intestine and other mucosal surfaces. As shown in
Figure 6a, the survival rate of MCPIP1-deficient mice was
significantly improved at 10 weeks by antibiotic treatment; 80% of
untreated MCPIP1/ died, whereas only 33% of antibiotic
MCPIP1/ died by 10 weeks of age. Spleens from antibiotic-treated
MCPIP1-deficient mice were much smaller than those from untreated
MCPIP1-deficient mice (Figure 6b). Furthermore, the mRNA expres-
sion levels encoding inflammatory cytokines, such as IFN-g, IL-13
and IL-17, but not IL-6, were significantly decreased in the spleens
from antibiotic-treated MCPIP1-deficient mice compared with
untreated mice (Figure 6c).
DISCUSSION
The key findings of the current study are that: (1) primary and
secondary lymphoid organs of MCPIP1-deficient mice had signficant
architectural abnormalities, and these abnormalities progressed with
age; (2) MCPIP1-deficient mice spontanously developed profound,
age-dependent, systemic inflammatory responses that involved
both innate and adaptive immunity, as evidenced by marked
infiltration of neutrophils, lymphocytes and macrophages into the
lungs and liver, and by increased deposition of IgG and IgM in the
spleen, skin and lungs; (3) overall cellular composition of the spleen
was markedly affected by MCPIP1 deficiency, as evidenced by greatly
decrease in the numbers of B cells, marked increase in the numbers of
neutrophils, slight decreases in T cells, and an increase in the
proportion of the B-cell lineage that had differentiated into plasma
cells; (4) abnormal T-cell populations in the spleen of MCPIP1-
deficient mice that demonstrated enhanced immune activation; and
(5) protein and mRNA levels for numerous markers of innate and
adaptive immunity were elevated in the sera and spleens from
Figure 5 Expression of proinflammatory cytokines, chemokines and other markers of inflammation from MCPIP1/ and MCPIP1þ /þ mice. (a) Enzyme-
linked immuno sorbent assay analysis of serum levels of proinflammatory cytokines, chemokines and other markers of inflammation of MCPIP1-deficient
mice (KO) and their wild-type littermates (WT) at the age of 6–8 weeks (n¼3 per genotype). Data are presented as mean±s.d., n¼3. *Po0.01 vs wild-
type mice. (b–d) Quantitative PCR (QPCR) analysis of mRNA levels of proinflammatory cytokines, chemokines and other markers of inflammation in spleens
of MCPIP1-deficient mice and their wild-type littermates at the age of 6–8 weeks (n¼3 per genotype). Data are presented as mean±s.d., n¼3. *Po0.01
vs wild-type mice. (e) QPCR analysis of the mRNA levels of Zc3h12b, Zc3h12c and Zc3h12d in the spleens of MCPIP1-deficient mice and their wild-type
littermates at the age of 6–8 weeks (n¼3 per genotype).
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MCPIP1-deficient mice. Taken together, these results suggest that
MCPIP1-deficient mice developed a lupus-like pathological changes
except no glomerulonephritis.
The findings here support our original report that MCPIP1 is a
negative regulator of inflammatory activation of macrophages,4 and
extend our subsequent observations of the spontaneous, fatal,
inflammatory disease that develops in MCPIP1-deficient mice.8
In a report from Akira’s group, Zc3h12a-deficient mice generated
with a mixed C57BL/6 and 129/svj background showed a phenotype
similar to our mouse line,9 suggesting that MCPIP1/Zc3h12a is
essential to control inflammatory response and immune homeostasis.
In addition, the phenotypes developed in MCPIP1-deficient
mice share many similarities with mice deficient in TTP, roquin,
TANK and TIPE2 and so on,14–17 suggesting that immune homeo-
stasis is maintained by multiple-negative regulators that could
not compensate for each other. For example, the phenotypes of
MCPIP1-deficient mice are resembled with the sanroque homozygous
mice, including enlarged spleen and lymph nodes, anemia, hepatitis,
autoantibody production and accumulation of IgG-containing
immnue complexes.15 However, MCPIP1-deficenct mice did not
show marked proliferative glomerolonephritis as the sanroque
mice and MCPIP1-deficient mice showed obvious abnormalities in
the innate arm that sanroque mice did not show. In addition,
MCPIP1-deficient mice showed many phenotypes that resembled
with TTP-knockout mice such as inflammatory arthritis,
dermatitis, cachexia and autoimmunity.14 In TTP-knockout mice,
the phenotypes can be largely attributed to the incresed production
of TNFa, whereas MCPIP1-deficient mice showed profound
changes of many inflammatiory cytokines. In a recent report,
myloid-specific TTP-knockout mice showed extremely sensitive to
lipopolysaccharide-induced septic shock,18 which is very similar
to MCPIP1-deficent mice.10 Considering roquin (sanroque), TTP
(zfp36) and MCPIP1 (Zc3h12a) are all CCCH-zinc finger containing
proteins, they may share some similar role and mechanisms in
maintaing immune homeostasis.
Under physiological conditions, the commensal microbiota of
mucosal surfaces represents the largest source of ligands for Toll-like
receptors, which serve as the principle sensors of the innate immune
system. It has also been reported that Toll-like receptor signaling by
this commensal microbiota contributes to the pathogenesis of
autoimmune diseases.12,13 To test whether commensal microbiota
contributed to the pathogenesis of inflammatory disease in MCPIP1-
deficient mice, we treated these mice for 10 weeks with a combination
of antibiotics (ampicillin, neomycin, vancomycin and metronidazole)
that would have a collective broad spectrum of antibacterial activity,
and would be expected to eradicate much of commensal microbiota
from the intestine and other mucosal surfaces. Importantly, treatment
of MCPIP1-deficient mice with antibiotics reduced abnormalities
observed in the spleens, increased survival and decreased mRNA levels
for inflammatory cytokines. Consequently, this series of experiments
clearly supported the conclusion that commensal microbiota
contributed to the development of the inflammatory and immune
disorders developing in MCPIP1-deficient mice.
The molecular mechanisms underlying the pathological changes in
MCPIP1-deficient mice are still not completely understood. The
initial report3 that MCPIP1 may be a transcription factor is not
supported by following studies. Emerging data indicated that
MCPIP1 is a novel RNase, which may selectively target mRNA of
Figure 6 Antibiotic treatment improved the life span and inflammatory syndrome of MCPIP1/ mice. (a) MCPIP1-deficient mice were treated orally with
the drinking water containing ampicillin (1 g l1), neomycin (1g l1), vancomycin (0.5 g l1) and metronidazole (1 g l1) (n¼6) or normal drinking water
(n¼10) from birth to 10 weeks of age. The survival rates from both groups were recorded and plotted. *Po0.05. (b) Representive gross morphology and
weight of spleens from antibiotic treated and untreated MCPIP1þ /þ and MCPIP1/ mice. *Po0.05, n¼3. (c) QPCR analysis of mRNA levels of
proinflammatory cytokines in the spleens from antibiotic treated and untreated MCPIP1þ /þ and MCPIP1/ mice. Data are represented as mean±s.d.,
n¼3. *Po0.01 vs untreated MCPIP1/ mice. The solid bar indicates MCPIP1/ mice and the open bar indicates wild-type mice.
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some inflammatory cytokines such as IL-6, IL-1b, IL-2 and IL-12p40
for degradation.9,19–21 However, how MCPIP1 selectively target
specific substrates is not clear. We recently observed that MCPIP1
forms granule-like structure in cytosol and is associated with the key
components of RNA-induced silencing complex, such as Argnaute 2
and GW-182 (Qi et al.22). These data suggest that MCPIP1 may co-
operate with microRNA effector pathway to silence the expression of
specific inflammatory mRNAs. The previous work from us and others
also suggests that MCPIP1 can inhibit inflammatory signaling
especially JNK and nuclear factor-kB signal pathways.8,23,24 Taken
together, these results suggest that MCPIP1 may function as a
multifunctional molecule that downregulates inflammatory and
immue responses through multiple mechanisms.
METHODS
Mice
MCPIP1-deficient (MCPIP1/) mice and their wild-type (MCPIP1þ /þ )
littermates on a C57BL/6 background were generated as described previously,8
and housed in the Laboratory Research Animal Center at the University of
Missouri-Kansas City. All mice were maintained in sterilized filter-top cages
and fed autoclaved food and water under specific pathogen-free conditions.
Both male and female mice used were between the ages of 6 and 12 weeks,
unless indicated otherwise. Experimental procedures were approved by the
Animal Care and Use Committee of University of Missouri-Kansas City.
Histological analyses
Tissue samples were fixed in 10% neutral buffered formalin for 1 day,
subsequently routinely processed and embedded in paraffin. Sections of
5mm thickness were stained with hematoxylin and eosin. Slides were
interpreted by a board-certified pathologist blinded to the genotypes of the
specimens.
Immunohistochemistry and immunofluorescence
Five micrometers sections of paraffin-embedded material were used for the
immunologic staining. After rehydration, endogenous peroxidase was
quenched by incubation of the sections in 0.3% H2O2 diluted in methanol
for 30 min. Thereafter, antigen retrieval was performed using either citrate
(pH 6.0) or EDTA (pH 8.0) for 15 min in the autoclave. After cooling, the
slides were rinsed with phosphate-buffered saline containing 0.5% Triton
X-100 (5 min), followed by phosphate-buffered saline only (3 5 min). After
preincubation with normal donkey serum or normal goat serum, antibodies
against CD45 and F4/80 (Abcam, Cambridge, MA, USA), DyLight 488 anti-
mouse IgM, and DyLight 594 anti-mouse IgG (Vector Labs, Burlingame, CA,
USA), were used for the analysis. CD45 (marker of B cells) and F4/80 (marker
of macrophages) were detected with secondary antibody conjugated to
horseradish peroxidase, followed by the addition of a chromogen substrate.
DyLight 488 anti-mouse IgM and DyLight 594 anti-mouse IgG were used for
immunofluorescence. Sections were counterstained with hematoxylin and
40,60-diamidino-2-phenylindole for immunohistochemistry and immuno-
fluorescence, respectively.
Flow cytometry
Mouse spleen cells were collected and the red blood cells were lysed with BD
lysing buffer (BD Biosciences, San Jose, CA, USA). The non-lysed cells were
further stained with antibodies against surface markers to distinguish
subpopulations. For cytokine expression assay, the cells were first cultured
with RPMI1640 medium containing 10% fetal bovine serum (Hyclone, South
Logan, UT, USA) for 5 h in the presence of 1mg ml1 brefeldin A (BFA),
1mg ml1 ionomycin and 50 ng ml1 phorbol myristate acetate (PMA) (all
from Sigma-Aldrich, St Louis, MO, USA) and then labeled. All of the
intracellular labeling was performed after the surface marker staining with
Foxp3 staining buffer set (eBioscience, San Diego, CA, USA) following the
manufacturer’s instructions. The flow-cytometry antibodies used include anti-
CD3e (PerCP-Cy5.5), anti-B220 (phycoerythrin, PE-Cy7), anti-CD4 (allophy-
cocyanin), anti-CD8 (fluorescein isothiocyanate isomer, FITC), anti-CD62L
(PE), anti-IFN-g (PE), anti-IL-4 (PE), anti-IL-17 (PE), anti-Foxp3 (PE), anti-
CD11b (PE), anti-CD115 (PerCP-eFluor710), anti-Ly-6C (APC) (all the above
from eBioscience), anti-CD138 (APC) and anti-Ly-6G (FITC) (both from BD
Biosciences) antibodies. Data analysis were performed using the CellQuest
software (BD Bioscience).
Enzyme-linked immuno sorbent assay and quantitative PCR
Enzyme-linked immuno sorbent assay was performed by using Bio-Plex Pro
(Bio-Rad, Hercules, CA, USA) Mouse Cytokine 23-plex assay according to the
manufacturer’s instruction. Real-time PCRs were performed using SYBR green
PCR master mix (Applied Biosystems, Foster City, CA, USA) on a StepOne-
Plus real-time PCR system (Applied Biosystems) following standard proce-
dures. Briefly, single-stranded complementary DNA was synthesized from 1mg
of total RNA using High Capacity complementary DNA Reverse Transcription
Kit (Applied Biosystems). For PCR reactions, 1ml of DNA template, 0.3ml of
forward and reverse primers (10 mmol l1 each), 10ml of SYBR green PCR
Master Mix and 8.4ml of water were added to a final volume of 20ml. Thermal
cycling was performed as follows: 95 1C for 3 min as initial denaturing,
followed by 40 cycles of 94 1C for 30 s, 601C for 30 s, and a final extension at
72 1C for 2 min. Threshold cycles (CT values) were determined using the
StepOne software (Applied Biosystems). The sequence of the primers used for
the PCR was shown in Supplementary Table S1. Real-time PCR results were
normalized using b-actin as an internal control. Relative mRNA levels were
calculated from the CT values for each sample.
Antibiotic treatment
Both MCPIP1-deficient mice and their wild-type littermates received untreated
water or treated water containing ampicillin (1 g l1), neomycin (1 g l1),
vancomycin (0.5 g l1) and metronidazole (1 g l1) from birth to 10 weeks.
The body weight and survival rate were recorded. At 10 weeks, surviving mice
were killed and the spleens were weighed and photographed. Cytokine
expression in the spleen was measured by quantitative PCR.
Statistics
Data were expressed as mean±s.d. For comparison between two groups the
unpaired Student’s test was used. For multiple comparisons, analysis of
variance followed by unpaired Student’s test was used. A value of Po0.05
was considered significant.
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